Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01908686 · ClinicalTrials.gov registry record · NA

Pivotal Response Treatment for Children With Autism Spectrum Disorders

A NA study of Autism Spectrum Disorders, sponsored by Yale University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01908686 is a NA study of Autism Spectrum Disorders that has completed, run by Yale University. The registered enrollment target is 40 participants, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01908686, a NA study of Autism Spectrum Disorders, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with Autism Spectrum Disorder (ASD) (Pivotal Response Treatment, PRT) to children ages four through six years of age with ASD. Specifically, children will be randomly assigned to receive either (1) 10 hours per week of intervention services, including two hours per week of parent education, and eight hours per week of direct clinician-delivered services, or (2) a treatment as usual control. Intervention will focus on enhancing the following developmental skills: expressive and receptive language, play, and social interaction. Outcome measures will address changes in the aforementioned domains during structured observation and standardized assessment.

Conditions Studied

Interventions

  • BEHAVIORAL Pivotal Response Training

Study Locations (1)

Connecticut

  • Yale Child Study Center - Autism Program - New Haven

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-05
Est. Completion 2020-03-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01908686

The ClinicalTrials.gov registry entry for NCT01908686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (76% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Pivotal Response Training is the first listed.

NCT01908686 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01908686 about?

NCT01908686 is a clinical study titled "Pivotal Response Treatment for Children With Autism Spectrum Disorders". The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with Autism Spectrum Disorder (ASD) (Pivotal Response Treatment, PRT) to children ages four through six years of age with ASD. Specifically, children will be randomly assigned to receive ...

What is the current status of trial NCT01908686?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-05. Estimated completion is 2020-03-01.

What conditions does trial NCT01908686 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT01908686?

The interventions under investigation include: Pivotal Response Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01908686?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01908686 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.